Akston Biosciences
Mr. Herriman was Vice President of Operations of SmartCells, Inc. from 2004 through its sale to Merck & Co., Inc. in 2010. He was Vice President of Product Development at Neuromedical Systems, Inc. where he played a key role in helping to grow this start-up to a $100 million NASDAQ IPO, was a co-founder and President of Aspex Incorporated and Vice President of Operations at Media-Unbound, Inc., which was acquired by Rovi Corporation. Jim received his B.A. in Philosophy from Emory University.
This person is not in any offices
Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies.